1. figures from ABPI (2010).
http://www.abpi.org.uk/industry-info/knowledge-hub/medicines/Pages/nhs-expenditure.aspx#fig1
. Accessed 7 June 2011
2. Adams CP, Brantner VV (2010) Spending on new drug development. Health Econ 19:130–141
3. Braun MM et al (2010) Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years. Nat Rev Drug Discov 9:519–522
4. Campbell D, Chui M (2010) Pharmerging shake-up new imperatives in a redefined world. IMS Health,
http://www.imshealth.com/pharmergingreport2010
. Accessed 3 Dec 2010
5. Cyranoski D (2010) Shanghai by the numbers. Nature 466:518